Vidarabine [vidarabin]
- Terms
-
ARA-A
arabinoadenosin
arabinosyladenin
-
9-beta-Arabinofuranosyladenine
9-beta-D-Arabinofuranosyladenine
Adenine Arabinoside
alpha-Ara A
alpha-D-Arabinofuranosyladenine
Ara A
Ara-A
Arabinofuranosyladenine
Arabinosyladenine
beta-Ara A
Vira-A
A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.
- Annotation
- an antiviral & antimetabolite
- DUI
- D014740 MeSH Browser
- CUI
- M0022659
- CAS
- 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-
- Previous indexing
- Adenine (1972-1974); Nucleosides (1972-1974); Arabinose (1972-1974); Purines (1966-1973)
- History note
- 79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76
- Online note
- use VIDARABINE to search ARABINOFURANOSYLADENINE 1975-78
- Public note
- 79; was ARABINOFURANOSYLADENINE 1977-78, was ARABINOFURANOSYLADENINE see under PURINE NUCLEOSIDES 1975-76
Allowable subheadings
- AD
- administration & dosage 46
- AE
- adverse effects 19
- AG
- agonists
- AA
- analogs & derivatives 90
- AN
- analysis
- AI
- antagonists & inhibitors 2
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 18
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 43
- TO
- toxicity 2
- UR
- urine